387 related articles for article (PubMed ID: 21054565)
1. Depigmentation therapies for normal skin in vitiligo universalis.
AlGhamdi KM; Kumar A
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
[TBL] [Abstract][Full Text] [Related]
3. Depigmentation therapies in vitiligo.
Gupta D; Kumari R; Thappa DM
Indian J Dermatol Venereol Leprol; 2012; 78(1):49-58. PubMed ID: 22199060
[TBL] [Abstract][Full Text] [Related]
4. Depigmentation Therapies for Vitiligo.
Grimes PE; Nashawati R
Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
[TBL] [Abstract][Full Text] [Related]
5. Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study.
van Geel N; Depaepe L; Speeckaert R
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1121-7. PubMed ID: 25286980
[TBL] [Abstract][Full Text] [Related]
6. New and experimental treatments of vitiligo and other hypomelanoses.
Lotti T; Prignano F; Buggiani G
Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
[TBL] [Abstract][Full Text] [Related]
7. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
Hariharan V; Klarquist J; Reust MJ; Koshoffer A; McKee MD; Boissy RE; Le Poole IC
J Invest Dermatol; 2010 Jan; 130(1):211-20. PubMed ID: 19657355
[TBL] [Abstract][Full Text] [Related]
8. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
Mosher DB; Parrish JA; Fitzpatrick TB
Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
[TBL] [Abstract][Full Text] [Related]
9. [Acquired leukomelanoderma caused by topical depigmenting agents].
Grojean MF; Thivolet J; Perrot H
Ann Dermatol Venereol; 1982; 109(8):641-7. PubMed ID: 7187189
[TBL] [Abstract][Full Text] [Related]
10. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
Hossani-Madani A; Halder R
G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
[TBL] [Abstract][Full Text] [Related]
11. Update on skin repigmentation therapies in vitiligo.
Falabella R; Barona MI
Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC
Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876
[TBL] [Abstract][Full Text] [Related]
13. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.
Njoo MD; Vodegel RM; Westerhof W
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):760-9. PubMed ID: 10775851
[TBL] [Abstract][Full Text] [Related]
14. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
Oakley AM
Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
[TBL] [Abstract][Full Text] [Related]
15. Depigmentation therapy for vitiligo in patients with Fitzpatrick skin type VI.
Black W; Russell N; Cohen G
Cutis; 2012 Feb; 89(2):57-60. PubMed ID: 22474725
[TBL] [Abstract][Full Text] [Related]
16. Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole.
Di Nuzzo S; Masotti A
Clin Exp Dermatol; 2010 Mar; 35(2):215-6. PubMed ID: 20447090
[TBL] [Abstract][Full Text] [Related]
17. Vitiligo: an update on current pharmacotherapy and future directions.
Colucci R; Lotti T; Moretti S
Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073
[TBL] [Abstract][Full Text] [Related]
18. Vitiligo: new and emerging treatments.
Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
[TBL] [Abstract][Full Text] [Related]
19. Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1,064/532 nm), cryotherapy and chemical peels: A comparative study.
El-Mofty M; Mostafa WZ; Esmat S; Zayed A; Mashaly H; Hussien MF; Ismail SI
Dermatol Ther; 2019 Sep; 32(5):e13052. PubMed ID: 31376312
[TBL] [Abstract][Full Text] [Related]
20. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
